Abstract
BackgroundThe shape of the exposure-response curve for long-term ambient fine particulate (PM2.5) exposure and cause-specific mortality is poorly understood, especially for rural populations and underrepresented minorities.MethodsWe used hybrid machine learning and Cox proportional hazard models to assess the association of long-term PM2.5 exposures on specific causes of death for 53 million U.S. Medicare beneficiaries (aged ≥65) from 2000 to 2008. Models included strata for age, sex, race, and ZIP code and controlled for neighborhood socio-economic status (SES) in our main analyses, with approximately 4 billion person-months of follow-up, and additionally for warm season average of 1-h daily maximum ozone exposures in a sensitivity analysis. The impact of non-traffic PM2.5 on mortality was examined using two stage models of PM2.5 and nitrogen dioxide (NO2).ResultsA 10 μg /m3 increase in 12-month average PM2.5 prior to death was associated with a 5% increase in all-cause mortality, as well as an 8.8, 5.6, and 2.5% increase in all cardiovascular disease (CVD)-, all respiratory-, and all cancer deaths, respectively, in age, gender, race, ZIP code, and SES-adjusted models. PM2.5 exposures, however, were not associated with lung cancer mortality. Results were not sensitive to control for ozone exposures. PM2.5-mortality associations for CVD- and respiratory-related causes were positive and significant for beneficiaries irrespective of their sex, race, age, SES and urbanicity, with no evidence of a lower threshold for response or of lower Risk Ratios (RRs) at low PM2.5 levels. Associations between PM2.5 and CVD and respiratory mortality were linear and were higher for younger, Black and urban beneficiaries, but were largely similar by SES. Risks associated with non-traffic PM2.5 were lower than that for all PM2.5 and were null for respiratory and lung cancer-related deaths.ConclusionsPM2.5 was associated with mortality from CVD, respiratory, and all cancer, but not lung cancer. PM2.5-associated risks of CVD and respiratory mortality were similar across PM2.5 levels, with no evidence of a threshold. Blacks, urban, and younger beneficiaries were most vulnerable to the long-term impacts of PM2.5 on mortality.
Highlights
The shape of the exposure-response curve for long-term ambient fine particulate (PM2.5) exposure and cause-specific mortality is poorly understood, especially for rural populations and underrepresented minorities
In our paper of almost 19 million Medicare beneficiaries [4], for example, we showed 12 month average PM2.5 prior to death to be associated with increased all-cause, cardiovascular, respiratory, and lung cancer mortality, including from specific causes such as chronic obstructive pulmonary disease (COPD) and pneumonia mortality
We found a 10 μg /m3 increase in 12-month average PM2.5 to be associated with a 5% increase in all-cause mortality, as well as an 8.8, 5.6, and 2.5% increase in all cardiovascular disease (CVD), all respiratory, and all cancer-related deaths, respectively, in age, sex, race, ZIP code, and socio-economic status (SES)-adjusted models
Summary
The shape of the exposure-response curve for long-term ambient fine particulate (PM2.5) exposure and cause-specific mortality is poorly understood, especially for rural populations and underrepresented minorities. While our and other studies provide key evidence of PM2.5’s impacts on mortality from several specific causes of death, their findings were based on largely white and higher socio-economic status (SES) cohorts from specific locations [2, 9, 10] or living in urban areas close to air pollution monitoring sites [4]. Studies have expanded their geographic scope through the use of spatio-temporal models to predict exposures for participants living away from air pollution monitoring sites [5, 11, 12], most still largely focus on white, urban and higher SES populations [11, 12] or on all-cause [5] or CVD-related [13, 14] causes of death. New approaches are needed to examine PM2.5-associated risks of mortality more comprehensively, especially with regards to differentiation of risks for specific causes of death, for potentially susceptible sub-populations, and at low PM2.5 exposures
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have